<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03363425</url>
  </required_header>
  <id_info>
    <org_study_id>EE-2/04/31-01-2017</org_study_id>
    <nct_id>NCT03363425</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative iv Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption and Recovery After Abdominal Gynaecological Surgery</brief_title>
  <official_title>Effect of Perioperative Intravenous Infusion of Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption, Bowel Function and Recovery After Abdominal Gynaecological Surgery: a Randomised Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Athens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain continues to be inadequately managed and is the most common reason for the
      delay in discharge and unplanned hospital admission after surgery. Opioids remain the
      mainstay for postoperative analgesia. However, there is a continuous search for adjuvant
      therapies to reduce the doses of opioids and their related adverse effects, and extend the
      use of non-opioid analgesia for acute pain after abdominal surgery, thereby improving patient
      recovery. Currently there are no clinical trials that investigate the effect of intravenous
      lidocaine vs dexmedetomidine on postoperative pain, analgesic consumption and bowel function
      of patients undergoing abdominal gynaecological surgery. Purpose of this prospective double
      blind randomised clinical trial is the investigation of the effect of perioperative
      intravenous infusion of lidocaine vs dexmedetomidine vs placebo (Normal Saline 0,9%) on
      analgesic parameters and functional recovery of patients undergoing abdominal gynaecological
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic consumption 24 hours postop</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>morphine consumption from PCA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>0 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>2 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>4 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>8 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Numeric Pain Rating Scale- NPRS scale (0:no pain 10:worst pain ever)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hysterectomy</condition>
  <condition>Myomectomy</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline 0,9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Iv</intervention_name>
    <description>Lidocaine Iv</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine iv</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>placebo</description>
    <arm_group_label>Normal Saline 0,9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women

          -  ASA I-II

          -  30-70 years

          -  abdominal gynaecological surgery

        Exclusion Criteria:

          -  patient's refusal

          -  contraindication to the use of local anesthetics

          -  body mass index &gt;30 kg/m2

          -  history of cardiovascular diseases/ arrhythmias/ conduction abnormalities

          -  pregnant women

          -  significant renal or hepatic impairment

          -  insulin-dependent diabetes mellitus

          -  central nervous system disease or psychiatric diseases

          -  chronic use of opioids, steroids, clonidine (or other a2 agonist)

          -  use of drugs acting on the central nervous system or analgesics during the previous 2
             weeks

          -  drug/alcohol abuse

          -  inability to comprehend the following pain assessment scale
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aretaieio University Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Rekatsina</last_name>
      <phone>00306975104139</phone>
      <email>mrekatsina@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2017</study_first_submitted>
  <study_first_submitted_qc>December 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>December 6, 2017</last_update_submitted>
  <last_update_submitted_qc>December 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Athens</investigator_affiliation>
    <investigator_full_name>Staikou Chryssoula</investigator_full_name>
    <investigator_title>Assistant Professor of Anaesthesiology</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Analgesic Consumption</keyword>
  <keyword>Recovery</keyword>
  <keyword>Abdominal Gynaecological Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

